Increased risk of anti-drug antibodies to a second anti-TNF in patients who developed antibodies to the first anti-TNF

被引：0
|
作者：
Yanai, H. [1 ,2 ]
Amir, S. [2 ]
Biron, I. Avni [1 ,2 ]
Perets, T. Tsadok [1 ,2 ]
Shamir, R. [2 ,3 ]
Dotan, I. [1 ,2 ]
Assa, A. [2 ,3 ]
机构：
[1] Rabin Med Ctr, IBD Ctr, Div Gastroenterol, Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[3] Schneider Childrens Med Ctr, Inst Gastroenterol Nutr & Liver Dis, Petah Tiqwa, Israel
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P506
引用
收藏
页码：S439 / S439
页数：1
相关论文
共 50 条
  • [31] Is there a benefit from using a subsequent anti-TNF α medication in psoriasis patients who failed their first or second anti-TNF α agent?
    Alsharqi, Ali
    Parslew, Richard
    Dever, Bernadette
    Arslanian, Victoria
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2012, 53 (02) : E45 - E46
  • [32] Drug Survival of Second Biologic DMARD Therapy in Patients with Rheumatoid Arthritis: Comparison of a Second Anti-TNF with a Second Non-Anti-TNF after Discontinuation of a First Anti-TNF
    Wilke, T.
    Mueller, S.
    Majer, I.
    Heisen, M.
    Fuchs, A.
    Maywald, U.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [33] Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug
    Hyrich, K. L.
    Lunt, M.
    Dixon, W. G.
    Watson, K. D.
    Symmons, D. P. M.
    RHEUMATOLOGY, 2008, 47 (07) : 1000 - 1005
  • [34] Comparison the Long-Term Clinical Outcomes between Non Anti-TNF Versus Anti-TNF in RA Patients Who Failed to a First Anti-TNF
    Bogas, Patricia
    Plasencia-Rodriguez, Chamaida
    Balsa, Alejandro
    Navarro-Compan, Victoria
    Bonilla, Gema
    Moral Coro, Enrique
    Tornero, Carolina
    Nuno, Laura
    Peiteado, Diana
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [35] Is the Pharmacokinetic Profile of a First Anti-TNF Predictive of the Clinical Outcome and Pharmacokinetics of a Second Anti-TNF?
    Roblin, Xavier
    Verot, Celine
    Paul, Stephane
    Duru, Gerard
    Williet, Nicolas
    Boschetti, Gilles
    Del Tedesco, Emilie
    Peyrin-Biroulet, Laurent
    Phelip, Jean Marc
    Nancey, Stephane
    Flourie, Bernard
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (09) : 2078 - 2085
  • [36] The Immunogenicity to the First Anti-TNF Therapy Determines the Outcome of Switching to a Second Anti-TNF in Spondyloarthritis Patients.
    Plasencia, Chamaida
    Pascual-Salcedo, Dora
    Garcia-Carazo, Sara
    Bonilla, Gema
    Lojo, Leticia
    Nuno, Laura
    Villalba, Alejandro
    Peiteado, Diana
    Castillo-Gallego, Concepcion, Jr.
    Arribas, Florencia
    Nagore, Daniel
    Martin-Mola, E.
    Balsa, Alejandro
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S238 - S238
  • [37] The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients
    Chamaida Plasencia
    Dora Pascual-Salcedo
    Sara García-Carazo
    Leticia Lojo
    Laura Nuño
    Alejandro Villalba
    Diana Peiteado
    Florencia Arribas
    Jesus Díez
    Maria Teresa López-Casla
    Emilio Martín-Mola
    Alejandro Balsa
    Arthritis Research & Therapy, 15
  • [38] The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients
    Plasencia, Chamaida
    Pascual-Salcedo, Dora
    Garcia-Carazo, Sara
    Lojo, Leticia
    Nuno, Laura
    Villalba, Alejandro
    Peiteado, Diana
    Arribas, Florencia
    Diez, Jesus
    Teresa Lopez-Casla, Maria
    Martin-Mola, Emilio
    Balsa, Alejandro
    ARTHRITIS RESEARCH & THERAPY, 2013, 15 (04)
  • [39] Alternative for Anti-TNF Antibodies for Arthritis Treatment
    Paquet, Joseph
    Henrionnet, Christel
    Pinzano, Astrid
    Vincourt, Jean-Baptiste
    Gillet, Pierre
    Netter, Patrick
    Chary-Valckenaere, Isabelle
    Loeuille, Damien
    Pourel, Jacques
    Grossin, Laurent
    MOLECULAR THERAPY, 2011, 19 (10) : 1887 - 1895
  • [40] Anti-TNF antibodies for Crohn's disease
    Camilleri, Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (16): : 1662 - 1662
12345